SCHEMBL810233

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2964633	0.89	MAOB (0.52)	MAPTMAOBMAOAAPPSMN1; SMN2
	SCHEMBL4382272	0.86	MAOA (0.49)	MAPTMAOBMAOASMN1; SMN2
	SCHEMBL810695	0.86	MAPT (0.58)	MAPTMEN1KMT2AMAOBAPP
	SCHEMBL811395	0.86	MAOB (0.50)	MAPTMAOBMAOASMN1; SMN2
	SCHEMBL810159	0.86	MAOB (0.50)	MAPTMEN1KMT2AMAOBMAOA
	SCHEMBL29463873	0.86	MEN1 (0.53)	MAPTMEN1KMT2AMAOBMAOA
	SCHEMBL810842	0.86	MEN1 (0.53)	MAPTMEN1KMT2AMAOBMAOA
	SCHEMBL810443	0.85	MAOB (0.56)	MAOBMAOA
	SCHEMBL5064909	0.83	BCL2 (0.46)	MAPTMAOBMAOASMN1; SMN2
	SCHEMBL810308	0.83	VCAM1 (0.61)	MAPTMAOBMAOASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.